Showing results (51-60 of 72) with videos related to
Sort By:
Pageof 8
Molecules (Basel, Switzerland)|October 3, 2007
Flavonoids and strigolactones in root exudates as signals in symbiotic and pathogenic plant-fungus interactionsSiegrid Steinkellner, Venasius Lendzemo, Ingrid Langer, et al.Environmental Pollution (Barking, Essex : 1987)|February 14, 2012
Root anatomy and element distribution vary between two Salix caprea isolates with different Cd accumulation capacitiesMarek Vaculík, Cornelia Konlechner, Ingrid Langer, et al.The Biochemical Journal|February 21, 2002
Mutational analysis of the glucagon receptor: similarities with the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide (PACAP)/secretin receptors for recognition of the ligand's third residueJason Perret, Mélanie Van Craenenbroeck, Ingrid Langer, et al.Current Topics in Medicinal Chemistry|June 23, 2007
Validated ligand binding sites in CCK receptors. next step: computer-aided design of novel CCK ligandsIrina G Tikhonova, Esther Marco, Elodie Lahlou-Archer, et al.Environmental Pollution (Barking, Essex : 1987)|April 9, 2013
Expression of zinc and cadmium responsive genes in leaves of willow (Salix caprea L.) genotypes with different accumulation characteristicsCornelia Konlechner, Mine Türktaş, Ingrid Langer, et al.Oncology Letters|February 10, 2023
Bacterial RNA virus MS2 exposure increases the expression of cancer progression genes in the LNCaP prostate cancer cell lineSwapnil Ganesh Sanmukh, Nilton José Dos Santos, Caroline Nascimento Barquilha, et al.Molecular Pharmacology|June 25, 2010
Evidence that interaction between conserved residues in transmembrane helices 2, 3, and 7 are crucial for human VPAC1 receptor activationAnton O Chugunov, John Simms, David R Poyner, et al.International Journal of Pharmaceutics|February 7, 2016
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapyRémi Rosière, Matthias Van Woensel, Véronique Mathieu, et al.Molecular Pharmacology|November 19, 2005
Partial agonism, neutral antagonism, and inverse agonism at the human wild-type and constitutively active cholecystokinin-2 receptorsMagali Foucaud, Irina G Tikhonova, Ingrid Langer, et al.Cellular Signalling|May 22, 2002
VPAC(1) receptors have different agonist efficacy profiles on membrane and intact cellsIngrid Langer, Pascale Vertongen, Jason Perret, et al.Pageof 8